Gaber L W, Moore L W, Alloway R R, Amiri M H, Vera S R, Gaber A O
Department of Pathology, University of Tennessee-Memphis 38163, USA.
Transplantation. 1995 Aug 27;60(4):334-9. doi: 10.1097/00007890-199508270-00006.
Transplantation of kidneys from older donors is being advocated to expand the organ donor pool. However, the prevalence of atherosclerosis and age-induced renal structural alterations account for the variable function of allografts procured from these older donors. Pretransplant biopsies are sometimes used to evaluate kidneys from older donors, but to date there are no defined criteria correlating the extent of structural alterations in these kidneys to subsequent function. We investigated the effect of glomerulosclerosis, a marker for nephrosclerosis, on graft outcome. Sixty-five baseline biopsies of kidney allografts were retrospectively analyzed to identify a referent point of glomerulosclerosis that correlated with inferior graft outcome. Age and death from nontraumatic cerebrovascular injuries were the main correlates for donor glomerulosclerosis (P < 0.001). Allografts with poor function at 6 months defined as serum creatinine > 2.5 mg/dl (n = 13) or nephrectomy (n = 4) had a mean of 20% glomerulosclerosis at the time of implantation compared with only 2% sclerosis in allografts with good function (P < 0.05). Delayed graft function occurred in 22% and 33% of recipients with no glomerulosclerosis and those with less than 20% glomerulosclerosis, respectively. In contrast, patients receiving kidneys with > 20% sclerosis had an 87% incidence of delayed function (P < 0.05). Moreover, graft loss occurred in 7% of recipients of kidneys with less than 20% sclerosis and in 38% of recipients with > 20% sclerosis (P < 0.04). Measurements of serum creatinine in the donors did not distinguish the different degrees of glomerulosclerosis found on biopsy. Our data indicate that donor glomerulosclerosis greater than 20% increases the risk of delayed graft function and poor outcome of transplanted kidneys. Therefore, we advocate the use of routine biopsies of kidneys from older (> 50 yrs) donors and those donors with nontraumatic cerebrovascular accidents, despite seemingly normal preprocurement serum creatinine.
提倡使用老年供者的肾脏进行移植,以扩大器官供者库。然而,动脉粥样硬化的患病率以及年龄引起的肾脏结构改变导致了这些老年供者所提供的同种异体移植物功能各异。移植前活检有时用于评估老年供者的肾脏,但迄今为止,尚无明确标准将这些肾脏的结构改变程度与后续功能相关联。我们研究了肾小球硬化(一种肾硬化的标志物)对移植物结局的影响。对65例肾脏同种异体移植的基线活检进行回顾性分析,以确定与较差移植物结局相关的肾小球硬化参考点。年龄和非创伤性脑血管损伤导致的死亡是供者肾小球硬化的主要相关因素(P < 0.001)。6个月时功能不佳的同种异体移植物定义为血清肌酐> 2.5 mg/dl(n = 13)或肾切除术(n = 4),其植入时的平均肾小球硬化率为20%,而功能良好的同种异体移植物的硬化率仅为2%(P < 0.05)。无肾小球硬化和肾小球硬化率低于20%的受者中,分别有22%和33%发生移植肾功能延迟。相比之下,接受硬化率> 20%肾脏的患者发生移植肾功能延迟的发生率为87%(P < 0.05)。此外,硬化率低于20%的肾脏受者中7%发生移植物丢失,而硬化率> 20%的受者中这一比例为38%(P < 0.04)。供者血清肌酐的测量无法区分活检中发现的不同程度的肾小球硬化。我们的数据表明,供者肾小球硬化率大于20%会增加移植肾功能延迟和移植肾结局不佳的风险。因此,我们主张对年龄较大(> 50岁)的供者以及发生非创伤性脑血管意外的供者的肾脏进行常规活检,尽管获取前血清肌酐看似正常。